Data gathered: November 21
AI Stock Analysis - Exact Sciences (EXAS)
Analysis generated November 11, 2024. Powered by Chat GPT.
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of various types of cancer. The company’s flagship product, Cologuard, is a non-invasive stool-based DNA test for colorectal cancer. With a mission to detect cancer early and eradicate it, Exact Sciences has been at the forefront of medical technology in cancer screening. The company has a promising pipeline of diagnostic tests for various types of cancer and aims to continually innovate in the field of medical diagnostics.
Stock Alerts - Exact Sciences (EXAS)
 |
Exact Sciences | November 19 Price is up by 5.2% in the last 24h. |
|
Exact Sciences | November 18 Job postings are up by 34.7% in the last couple of days. |
|
Exact Sciences | November 14 Insider Alert: Conroy Kevin T is buying shares |
|
Exact Sciences | November 13 Web Traffic is up by 41.6% over the last month. |
Alternative Data for Exact Sciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 512 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,070,000 | Sign up | Sign up | Sign up |
| Employee Rating | 68 | Sign up | Sign up | Sign up |
| Google Trends | 54 | Sign up | Sign up | Sign up |
| Patents | 100 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 101 | Sign up | Sign up | Sign up |
| Facebook Followers | 10,103 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 5 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 11,180 | Sign up | Sign up | Sign up |
| Twitter Followers | 6,646 | Sign up | Sign up | Sign up |
| Twitter Mentions | 15 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 56 | Sign up | Sign up | Sign up |
| Linkedin Employees | 5,711 | Sign up | Sign up | Sign up |
About Exact Sciences
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers.
| Price | $53.42 |
| Target Price | Sign up |
| Volume | 1,240,000 |
| Market Cap | $9.75B |
| Year Range | $41.33 - $74.26 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Metis Global Partners LLC Takes $241,000 Position in Exact Sciences Co. (NASDAQ:EXAS)November 20 - ETF Daily News |
 |
Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right NowNovember 19 - Yahoo |
 |
Exact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript)November 19 - SeekingAlpha |
 |
EXAS Stock Set to Benefit From Favorable Study Data Backing MCED TestNovember 17 - Yahoo |
|
Amalgamated Bank Decreases Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)November 16 - ETF Daily News |
 |
Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More StockNovember 15 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 699M | 196M | 503M | -38M | -11M | -0.210 |
| Q2 '24 | 699M | 190M | 510M | -16M | 11M | -0.090 |
| Q1 '24 | 630M | 170M | 459M | -110M | -84M | -0.600 |
| Q4 '23 | 3.15B | 172M | 2.98B | -50M | -7.9M | -0.270 |
| Q3 '23 | 620M | 169M | 452M | 790,000 | 25M | 0.004 |
Insider Transactions View All
| Conroy Kevin T filed to buy 1,074,191 shares at $51.4. November 13 '24 |
| Baranick Brian filed to sell 12,758 shares at $70. October 9 '24 |
| Baranick Brian filed to sell 13,687 shares at $70. September 19 '24 |
| Herriott James filed to sell 9,866 shares at $60.2. May 2 '24 |
| COWARD D SCOTT filed to sell 44,644 shares at $60.2. May 2 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Joshua Gottheimer Democrat |
Jun 8, 24 | Sell | $1K - $15K |
| Joshua Gottheimer Democrat |
Mar 7, 24 | Sell | $1K - $15K |
| Kevin Hern Republican |
Feb 11, 24 | Sell | $1K - $15K |
Read more about Exact Sciences (EXAS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Exact Sciences?
The Market Cap of Exact Sciences is $9.75B.
What is the current stock price of Exact Sciences?
Currently, the price of one share of Exact Sciences stock is $53.42.
How can I analyze the EXAS stock price chart for investment decisions?
The EXAS stock price chart above provides a comprehensive visual representation of Exact Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Exact Sciences shares. Our platform offers an up-to-date EXAS stock price chart, along with technical data analysis and alternative data insights.
Does EXAS offer dividends to its shareholders?
As of our latest update, Exact Sciences (EXAS) does not offer dividends to its shareholders. Investors interested in Exact Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Exact Sciences?
Some of the similar stocks of Exact Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.